Your browser doesn't support javascript.
Pemphigus during the COVID-19 Epidemic: Infection Risk, Vaccine Responses and Management Strategies.
Huang, Xueyi; Liang, Xiaoqian; Zhang, Jiao; Su, Hang; Chen, Yongfeng.
  • Huang X; Dermatology Hospital, Southern Medical University, Guangzhou 510091, China.
  • Liang X; Dermatology Hospital, Southern Medical University, Guangzhou 510091, China.
  • Zhang J; Dermatology Hospital, Southern Medical University, Guangzhou 510091, China.
  • Su H; Dermatology Hospital, Southern Medical University, Guangzhou 510091, China.
  • Chen Y; Dermatology Hospital, Southern Medical University, Guangzhou 510091, China.
J Clin Med ; 11(14)2022 Jul 08.
Article in English | MEDLINE | ID: covidwho-1928589
ABSTRACT
Pemphigus is a rare autoimmune blistering disease, involving potentially life-threatening conditions often requiring immunosuppression. Currently, the COVID-19 pandemic caused by severe acute respiratory disease coronavirus 2 (SARS-CoV-2) infection has become a global public emergency. Vaccines are the most effective defense against COVID-19 infection. However, in clinic, there are cases of new onset or flare of pemphigus following COVID-19 vaccination, where vaccines have manifested significantly desirable risk-benefit profiles for patients. Although Rituximab, as first-line therapy, may impair humoral immunity, pemphigus may not predispose to develop COVID-19 infection compared to a healthy population. Conversely, delay or interruption of immunosuppressants probably results in unfavorable clinical outcomes for disease progression. Overall, clinicians should encourage their patients to undergo the vaccination after a comprehensive assessment. The definite association between COVID-19 vaccination and pemphigus remains to be further elucidated. Herein, we provide an overview of the published studies to date on COVID-19 and pemphigus as well as the exploration of their complicated interplay. In addition, we discuss the management strategies for pemphigus patients in this special period, in an effort to more effectively establish a standard treatment paradigm for this particular patient group.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Topics: Vaccines Language: English Year: 2022 Document Type: Article Affiliation country: Jcm11143968

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Topics: Vaccines Language: English Year: 2022 Document Type: Article Affiliation country: Jcm11143968